SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of the International Association of Physicians in AIDS Care (JIAPAC)
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Spira, S. C.
Right arrow Articles by Wainberg, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spira, S. C.
Right arrow Articles by Wainberg, M. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Jewish Religious Ethics Mandate Access to Antiretroviral Drugs in Developing Countries

Shalom C. Spira, BSc

Division of Religious Studies, Lady Davis Institute-Jewish General Hospital, Montréal, Québec, Canada

Mark A. Wainberg, PhD

McGill University AIDS Centre, Lady Davis Institute-Jewish General Hospital, Montréal, Québec, Canada

The plight of millions of HIV-infected individuals without access to antiretroviral (ARV) medications constitutes an enormous problem. Religious values can influence policymakers in public and personal health issues. This article posits that Jewish religious law mandates the broadest possible access to ARV medications for HIV-infected individuals, and argues that wealthy countries must assist poorer ones to facilitate access.

Key Words: antiretroviral drugs • access • developing countries • Jewish ethics • drug resistance

Journal of the International Association of Physicians in AIDS Care (JIAPAC), Vol. 3, No. 1, 7-11 (2004)
DOI: 10.1177/154510970400300102


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement